$44.99
0.06% day before yesterday
NYSE, Dec 27, 09:49 pm CET
ISIN
NL0012169213
Symbol
QGEN

QIAGEN NV Stock price

$44.99
+1.24 2.83% 1M
+3.89 9.46% 6M
+0.22 0.48% YTD
+0.17 0.37% 1Y
-12.83 22.20% 3Y
+10.28 29.61% 5Y
+19.85 78.98% 10Y
NYSE, Closing price Fri, Dec 27 2024
-0.02 0.04%
ISIN
NL0012169213
Symbol
QGEN
Sector

Key metrics

Market capitalization $9.98b
Enterprise Value $10.42b
P/E (TTM) P/E ratio 111.44
EV/FCF (TTM) EV/FCF 22.48
EV/Sales (TTM) EV/Sales 5.30
P/S ratio (TTM) P/S ratio 5.08
P/B ratio (TTM) P/B ratio 2.83
Revenue growth (TTM) Revenue growth 0.62%
Revenue (TTM) Revenue $1.97b
EBIT (operating result TTM) EBIT $471.97m
Free Cash Flow (TTM) Free Cash Flow $463.48m
Cash position $1.48b
EPS (TTM) EPS $0.40
P/E forward 101.46
P/S forward 5.04
EV/Sales forward 5.26
Short interest 2.18%
Show more

Is QIAGEN NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

QIAGEN NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a QIAGEN NV forecast:

15x Buy
65%
8x Hold
35%

Analyst Opinions

23 Analysts have issued a QIAGEN NV forecast:

Buy
65%
Hold
35%

Financial data from QIAGEN NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,966 1,966
1% 1%
100%
- Direct Costs 735 735
0% 0%
37%
1,231 1,231
1% 1%
63%
- Selling and Administrative Expenses 359 359
5% 5%
18%
- Research and Development Expense 191 191
3% 3%
10%
681 681
6% 6%
35%
- Depreciation and Amortization 209 209
0% 0%
11%
EBIT (Operating Income) EBIT 472 472
8% 8%
24%
Net Profit 93 93
72% 72%
5%

In millions USD.

Don't miss a Thing! We will send you all news about QIAGEN NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

QIAGEN NV Stock News

Neutral
Business Wire
16 days ago
REDWOOD CITY, Calif. & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN, Frankfurt Prime Standard: QIA) today announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data. Leveraging AI technology, IPA Interpret helps distill complex differential expression analyses into actionable ...
Neutral
Business Wire
23 days ago
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has reached a significant milestone with over 1,000 placements of the EZ2 Connect automated sample preparation instrument, an advancement of the EZ1 instrument line. Launched in 2021, the updated EZ2 Connect has quickly become a market-leading instrument for sample prepar...
Neutral
Business Wire
about one month ago
BARCELONA, Spain & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to move its QIAstat-Dx operations within the Barcelona area to a new site in Esplugues de Llobregat as part of a multi-year investment to strengthen this business. Set to open in early 2026, the new site will cover the entire value chain for the QIAstat-Dx system,...
More QIAGEN NV News

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Thierry Bernard
Employees 5,967
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today